Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for GRRMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
November 30, 2025 5.315B
August 31, 2025 5.486B
May 31, 2025 5.399B
February 28, 2025 5.034B
November 30, 2024 4.055B
August 31, 2024 3.944B
May 31, 2024 3.848B
February 29, 2024 3.754B
November 30, 2023 3.805B
August 31, 2023 3.643B
May 31, 2023 3.532B
February 28, 2023 3.461B
November 30, 2022 3.508B
August 31, 2022 3.558B
May 31, 2022 3.412B
February 28, 2022 3.325B
November 30, 2021 3.297B
August 31, 2021 3.233B
May 31, 2021 3.249B
February 28, 2021 3.161B
November 30, 2020 3.181B
August 31, 2020 3.088B
May 31, 2020 2.931B
February 29, 2020 2.911B
November 30, 2019 2.963B
Date Value
August 31, 2019 3.024B
May 31, 2019 3.053B
February 28, 2019 3.062B
November 30, 2018 3.135B
August 31, 2018 3.085B
May 31, 2018 2.620B
February 28, 2018 2.913B
November 30, 2017 2.964B
August 31, 2017 2.682B
May 31, 2017 2.574B
February 28, 2017 2.522B
November 30, 2016 2.568B
August 31, 2016 2.672B
May 31, 2016 2.627B
February 29, 2016 2.563B
November 30, 2015 2.610B
August 31, 2015 1.870B
May 31, 2015 1.865B
February 28, 2015 1.902B
November 30, 2014 2.135B
August 31, 2014 2.147B
May 31, 2014 2.228B
February 28, 2014 2.214B
November 30, 2013 2.200B
August 31, 2013 2.125B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Sartorius AG 10.98B
SCHOTT Pharma AG & Co. KGaA 1.937B
Agilent Technologies, Inc. 13.06B
Bio-Rad Laboratories, Inc. 10.25B
Bruker Corp. 6.053B

Total Assets (Quarterly) Related Metrics